Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case Reports

<b>Background</b>: Among rheumatologic diseases following therapy with immune checkpoint inhibitors (ICIs), the cases of cancer patients diagnosed as having polymyalgia rheumatica (PMR), particularly with nivolumab and pembrolizumab, has been steadily rising in published reports. <b>Objectives</b>:...

詳細記述

書誌詳細

主要な著者:	Ciro Manzo, Marco Isetta, Alberto Castagna, Melek Kechida
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2025-04-01
シリーズ:	Medical Sciences
主題:	polymyalgia rheumatica immunotherapy immune checkpoints inhibitors systematic review adverse drug reaction case reports
オンライン･アクセス:	https://www.mdpi.com/2076-3271/13/2/34
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!